These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 27696464)

  • 1. Hazards in chromatographic bioanalysis method development and applications.
    Hooshfar S; Bartlett MG
    Biomed Chromatogr; 2017 Jan; 31(1):. PubMed ID: 27696464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioanalytical method development and validation: Critical concepts and strategies.
    Moein MM; El Beqqali A; Abdel-Rehim M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1043():3-11. PubMed ID: 27720355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulated bioanalysis of oligonucleotide therapeutics and biomarkers: qPCR versus chromatographic assays.
    Wang L; Meng M; Reuschel S
    Bioanalysis; 2013 Nov; 5(22):2747-51. PubMed ID: 24256356
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel LC-MS approach for the detection of metabolites in DMPK studies.
    Plumb RS; Mather J; Little D; Rainville PD; Twohig M; Harland G; Kenny DJ; Nicholson JK; Wilson ID; Kass IJ
    Bioanalysis; 2010 Oct; 2(10):1767-78. PubMed ID: 21083328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrophilic Interaction Liquid Chromatography/Mass Spectrometry: An Attractive and Prospective Method for the Quantitative Bioanalysis in Drug Metabolism.
    Li Z; Han J; Sun SA; Chen K; Tang DQ
    Curr Drug Metab; 2016; 17(4):386-400. PubMed ID: 26651973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of HILIC-MS in quantitative bioanalysis of drugs and drug metabolites.
    Hsieh Y
    J Sep Sci; 2008 May; 31(9):1481-91. PubMed ID: 18428187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in metabolite identification and quantitative bioanalysis by LC-Q-TOF MS.
    Xie C; Zhong D; Yu K; Chen X
    Bioanalysis; 2012 May; 4(8):937-59. PubMed ID: 22533568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies in quantitative LC-MS/MS analysis of unstable small molecules in biological matrices.
    Li W; Zhang J; Tse FL
    Biomed Chromatogr; 2011 Jan; 25(1-2):258-77. PubMed ID: 21204113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tracking problems and possible solutions in the quantitative determination of small molecule drugs and metabolites in biological fluids using liquid chromatography-mass spectrometry.
    Bakhtiar R; Majumdar TK
    J Pharmacol Toxicol Methods; 2007; 55(3):262-78. PubMed ID: 17174577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technologies and strategies to characterize and quantitate metabolites in drug discovery and development.
    Ravindran S; Jadhav A; Surve P; Lonsane G; Honrao P; Nanda B
    Biomed Chromatogr; 2014 Nov; 28(11):1547-53. PubMed ID: 25175001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS.
    Xu RN; Fan L; Rieser MJ; El-Shourbagy TA
    J Pharm Biomed Anal; 2007 Jun; 44(2):342-55. PubMed ID: 17360141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of evaluating the chemical structures and strategies to avoid pitfalls in quantitative bioanalysis.
    Licea-Perez H; Evans CA; Summerfield SG
    Bioanalysis; 2019 Jan; 11(2):85-101. PubMed ID: 30475061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in high-sensitivity hybrid LC-MS/MS methods for the bioanalysis of protein drugs and performance tests for their validation.
    Duggan JX
    Bioanalysis; 2018 Jul; 10(13):983-986. PubMed ID: 29993264
    [No Abstract]   [Full Text] [Related]  

  • 14. Separation and sample pre-treatment in bioanalysis using monolithic phases: A review.
    Saunders KC; Ghanem A; Boon Hon W; Hilder EF; Haddad PR
    Anal Chim Acta; 2009 Oct; 652(1-2):22-31. PubMed ID: 19786168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrophilic interaction liquid chromatography-tandem mass spectrometry for drug development.
    Hsieh Y
    Curr Drug Discov Technol; 2010 Sep; 7(3):223-31. PubMed ID: 20843291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid chromatography coupled with tandem mass spectrometry for the bioanalysis of proteins in drug development: practical considerations in assay development and validation.
    Liu G; Ji QC; Dodge R; Sun H; Shuster D; Zhao Q; Arnold M
    J Chromatogr A; 2013 Apr; 1284():155-62. PubMed ID: 23466204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput quantitative bioanalysis by LC/MS/MS.
    Jemal M
    Biomed Chromatogr; 2000 Oct; 14(6):422-9. PubMed ID: 11002279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioanalytical hydrophilic interaction chromatography: recent challenges, solutions and applications.
    Xu RN; Rieser MJ; El-Shourbagy TA
    Bioanalysis; 2009 Apr; 1(1):239-53. PubMed ID: 21083199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of high-resolution mass spectrometry to investigate a metabolite interference during liquid chromatography/tandem mass spectrometric quantification of a small molecule in toxicokinetic study samples.
    Furlong M; Bessire A; Song W; Huntington C; Groeber E
    Rapid Commun Mass Spectrom; 2010 Jul; 24(13):1902-10. PubMed ID: 20533320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How much separation for LC-MS/MS quantitative bioanalysis of drugs and metabolites?
    Tan A; Fanaras JC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1084():23-35. PubMed ID: 29558737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.